TNXP
Tonix Pharmaceuticals Holding Corp.
-0.39 (-3.32%)11.37USD167K成交股數195M市值–本益比(近四季)6.7股價營收比+577.9%營收年增(近四季)2026-11-09下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 13.5M+578% | 6.9M+183% | 5.4M+91% | 3.3M+49% | 2.0M-20% | 2.4M | 2.8M-29% | 2.2M | 2.5M | – | 4.0M | – |
| 營業成本 | 703K | 1.6M | 1.1M | 1.4M | 3.3M | 943K | 1.6M | 3.4M | 1.7M | – | 2.4M | – |
| 毛利 | 12.8M-1108% | 5.3M+257% | 4.3M+242% | 1.9M-266% | −1.3M-255% | 1.5M | 1.3M-22% | −1.2M | 822K | – | 1.6M | – |
| 毛利率 | 94.8% | 77.1% | 80.4% | 58.4% | -63.8% | 61.2% | 44.9% | -52.5% | 33.1% | – | 40.5% | – |
| 研發費用 | 19.4M | 18.2M | 16.9M | 9.3M | 10.8M | 7.4M | 9.1M | 9.7M | 12.9M | 17.1M | 21.1M | 22.0M |
| 銷售管理費用 | 36.0M | 28.6M | 35.7M | 25.7M | 16.2M | 10.1M | 7.7M | 7.5M | 9.3M | 11.6M | 8.7M | 7.0M |
| 營業利益 | −42.5M+50% | −41.5M+159% | −48.3M+210% | −33.1M-57% | −28.3M+33% | −16.1M-41% | −15.6M-45% | −77.3M+167% | −21.4M | −27.3M | −28.1M | −29.0M |
| 營業利益率 | -314.1% | -603.9% | -895.8% | -1,005.1% | -1,416.2% | -660.9% | -551.2% | -3,501.6% | -860.2% | – | -705.6% | – |
| 稅後淨利 | −40.6M+43% | −40.2M+139% | −46.9M+230% | −32.0M-59% | −28.3M+89% | −16.8M-38% | −14.2M-49% | −78.8M+178% | −14.9M | −27.3M | −28.0M | −28.4M |
| 淨利率 | -299.4% | -584.4% | -870.3% | -972.9% | -1,415.0% | -692.8% | -503.6% | -3,567.8% | -601.9% | – | -701.3% | – |
| 稀釋 EPS | -2.44-37% | -2.93+3% | -4.28-81% | -3.59-100% | -3.86-99% | -2.84-100% | -22.68-41% | -1920.85+3802% | -535.72 | -14629.18 | -38.63 | -49.23 |
| 稀釋股數 | 16.6M | 13.7M | 8.5M | 8.9M | 7.3M | 5.9M | 627K | 41.0K | 27.9K | 7.9K | 724K | 576K |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 176M | 185M | 208M | 190M | 125M | 132M | 28.2M | 4.2M | 7.0M | 24.9M | 6.9M | 25.6M |
| 應收帳款 | 11.8M | 8.8M | 6.3M | 3.5M | 2.3M | 3.3M | 4.0M | 3.3M | – | – | 1.6M | – |
| 存貨 | – | – | – | – | – | – | 7.9M | 9.5M | 12.4M | 13.6M | 13.3M | 13.7M |
| 總資產 | 254M | 258M | 277M | 252M | 187M | 193M | 95.0M | 70.3M | 135M | 154M | 139M | 160M |
| 有息負債 | – | – | – | – | – | – | 5.2M | 5.7M | 6.2M | 6.6M | – | – |
| 總負債 | 31.8M | 30.8M | 32.0M | 21.3M | 19.4M | 12.5M | 20.8M | 28.2M | 27.2M | 48.9M | 18.4M | 19.3M |
| 股東權益 | 222M | 227M | 245M | 231M | 168M | 180M | 74.2M | 42.1M | 108M | 106M | 121M | 140M |
| 負債比 | 12.5% | 11.9% | 11.6% | 8.4% | 10.3% | 6.5% | 21.9% | 40.1% | 20.1% | 31.7% | 13.2% | 12.1% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | 23.1M | −1.5M | 891K | 18.4M | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −42.3M+155% | – | – | – | −16.6M | – | – | −17.6M | – | – | – |
| 資本支出 | – | 1.7M | – | – | – | 6K | – | – | 108K | – | – | – |
| 自由現金流 | – | −44.0M+165% | – | – | – | −16.6M | – | – | −17.7M | – | – | – |
| 折舊攤銷 | 600K | 555K | 532K | 400K | 500K | 493K | 500K | 900K | 1.2M | 1.5M | 1.0M | 900K |
| 買回庫藏股 | – | – | – | – | 2.9M | 3.0M | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -639.9% | – | – | – | -682.8% | – | – | -712.4% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
產品／服務2025 年度 · 13.1M
| Zembrace Symtouch | 9.3M | 71.1% | +9.0% |
|---|---|---|---|
| Tosymra | 2.4M | 18.1% | +53.2% |
| Tonmya | 1.4M | 10.8% | – |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 13.1M | +29.8% | −124M | -946.2% | -14.57 | −103M |
| FY2024 | 10.1M | +29.9% | −130M | -1,288.3% | -176.60 | −61.0M |
| FY2023 | 7.8M | – | −117M | -1,501.8% | -14720.25 | −110M |
| FY2022 | – | – | −110M | –% | -20.01 | −146M |
| FY2021 | – | – | −92.3M | –% | -8.10 | −111M |
| FY2020 | – | – | −50.5M | –% | -0.55 | −57.1M |
| FY2019 | – | – | −28.6M | –% | -19.33 | −26.7M |
| FY2018 | – | – | −26.1M | –% | -259.85 | −24.0M |